Liquidia Corp (LQDA) Stock Price, Quote & News

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intr...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 919 328 4400

Fax: 919 328 4402

Website: www.liquidia.com

Address:

419 Davis Drive, Suite 100, Morrisville, United States

kcphaeton Sep. 18 at 8:19 PM

$LQDA $MNKD I think you’re being very critical of Gomer Pile. His subscribers consist of his mother-in-law and her husband and his parents and his siblings. You can’t appease them as suckers because they’ve lived with him so they know what they got. If he had real subscribers, they would cancel because his results really suck

0 · Reply

Georgeson Sep. 18 at 7:32 PM

$MNKD @NatesNotes you said to "keep it coming" so I will oblige. @NatesNotes is a con man who is trying constantly to appease his suckers (aka subscribers) and his own fragile ego, as well as find new suckers for his useless "investment" newsletter. How stupid is Nate? This is one of many examples: $MNKD To equate $LQDA market cap rise (which led to incredible share price rise) to MNKD market cap rise (which led to essentially flat share price over the last 10 years or just about any period of time) is so stupid that only @NatesNotes can be that stupid to convince suckers to subscribe to his newsletter. Thank you for your attention to this matter. #nateisanidiot #factsmatter #numbersdon'tLie

2 · Reply

Hamboning2026 Sep. 18 at 5:48 PM

$LQDA This stock does not hold its gains. Not sure how much more that needs to be said. Again, puts are free money here.

0 · Reply

KeelinTime Sep. 18 at 10:10 AM

$LQDA

0 · Reply

Zoeyface Sep. 18 at 9:48 AM

$LQDA The dip that keeps dipping.

0 · Reply

SteelerJon Sep. 17 at 9:28 PM

$LQDA 😎🏦🏦 https://www.defenseworld.net/2026/09/15/california-state-teachers-retirement-system-acquires-5835156-shares-of-liquidia-corporation-lqda.html

0 · Reply

BDE_Worldwide Sep. 17 at 8:24 PM

$LQDA weird day… 🤔

0 · Reply

KeelinTime Sep. 17 at 7:19 PM

$LQDA

0 · Reply

MrMulally Sep. 17 at 2:27 PM

$LQDA $70 again!!! 👏👏

0 · Reply

MarketPro Sep. 17 at 12:49 PM

$LQDA Chart Update:

0 · Reply

Liquidia Transcript: Wells Fargo 21st Annual Healthcare Conference

2026-09-03T11:35:15.000Z - 15 days ago

Liquidia granted Fast Track designation to Yutrepia inhalation powder

Sep 3, 2026, 7:30 AM EDT - 15 days ago

FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis

Sep 2, 2026, 8:30 AM EDT - 16 days ago

Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress

Sep 1, 2026, 8:30 AM EDT - 17 days ago

Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference

2026-08-17T10:07:55.000Z - 4 weeks ago

Liquidia reports Q2 EPS 74c, consensus 84c

2026-08-17T09:07:18.000Z - 4 weeks ago

Liquidia downgraded to Market Perform from Outperform at LifeSci Capital

2026-08-17T08:22:43.000Z - 4 weeks ago

Liquidia price target raised to $108 from $62 at Wells Fargo

2026-08-17T08:19:39.000Z - 4 weeks ago

Liquidia price target raised to $92 from $79 at BofA

2026-08-17T07:44:52.000Z - 4 weeks ago

Liquidia price target raised to $106 from $68 at Raymond James

Aug 12, 2026, 8:30 AM EDT - 5 weeks ago

Liquidia Earnings Call Transcript: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 5 weeks ago

Liquidia Earnings release: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 5 weeks ago

Liquidia Quarterly report: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 5 weeks ago

Liquidia Slides: Q2 2026

Aug 12, 2026, 6:30 AM EDT - 5 weeks ago

Liquidia Corporation Reports Second Quarter 2026 Financial Results

Jul 29, 2026, 8:30 AM EDT - 7 weeks ago

Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026

2026-07-23T16:00:17.000Z - 1 month ago

Liquidia price target raised to $130 from $75 at H.C. Wainwright

UTHR

2026-06-29T10:30:39.000Z - 2 months ago

Liquidia downgraded to Neutral from Buy at BofA

2026-06-22T11:32:52.000Z - 2 months ago

Liquidia price target raised to $109 from $59 at BTIG

Jun 16, 2026, 4:30 PM EDT - 3 months ago

Liquidia Transcript: AGM 2026

Jun 11, 2026, 8:30 AM EDT - 3 months ago

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

2026-06-08T13:08:28.000Z - 3 months ago

Liquidia announces inclusion in S&P SmallCap 600 Index

Jun 8, 2026, 8:30 AM EDT - 3 months ago

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

2026-06-05T10:55:08.000Z - 3 months ago

Liquidia price target raised to $75 from $67 at H.C. Wainwright

2026-06-04T19:30:40.000Z - 3 months ago

Raymond James sees positive readthrough for Liquidia from Hikma v. Amarin

2026-06-04T16:09:07.000Z - 3 months ago

Liquidia rises 17.6%

Jun 3, 2026, 12:45 PM EDT - 3 months ago

Liquidia Transcript: Jefferies Global Healthcare Conference 2026

May 27, 2026, 8:30 AM EDT - 3 months ago

Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

May 19, 2026, 9:30 AM EDT - 4 months ago

Liquidia Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference

May 13, 2026, 11:40 AM EDT - 4 months ago

Liquidia Transcript: Bank of America Global Healthcare Conference 2026

2026-05-12T18:47:33.000Z - 4 months ago

Liquidia price target raised to $67 from $55 at H.C. Wainwright

2026-05-12T11:38:21.000Z - 4 months ago

Liquidia price target raised to $62 from $51 at Wells Fargo

2026-05-11T21:57:52.000Z - 4 months ago

Liquidia price target raised to $60 from $57 at Jefferies

May 11, 2026, 8:30 AM EDT - 4 months ago

Liquidia Earnings Call Transcript: Q1 2026

May 11, 2026, 8:30 AM EDT - 4 months ago

Liquidia Earnings release: Q1 2026

May 11, 2026, 8:30 AM EDT - 4 months ago

Liquidia Quarterly report: Q1 2026

May 11, 2026, 8:30 AM EDT - 4 months ago

Liquidia Slides: Q1 2026

2026-05-11T11:28:55.000Z - 4 months ago

Liquidia reports Q1 EPS 52c, consensus 41c

May 11, 2026, 6:30 AM EDT - 4 months ago

Liquidia Corporation Reports First Quarter 2026 Financial Results

May 6, 2026, 8:30 AM EDT - 4 months ago

Liquidia Corporation to Participate in Upcoming Investor Conferences

May 4, 2026, 8:30 AM EDT - 4 months ago

Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Liquidia Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Liquidia Proxy statement: Proxy filing

Apr 15, 2026, 12:45 PM EDT - 5 months ago

Liquidia Transcript: 25th Annual Needham Virtual Healthcare Conference

Mar 5, 2026, 8:30 AM EST - 6 months ago

Liquidia Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Liquidia Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Liquidia Earnings release: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Liquidia Slides: Q4 2025

Mar 5, 2026, 6:30 AM EST - 6 months ago

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 26, 2026, 7:00 AM EST - 6 months ago

Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026

Jan 14, 2026, 8:15 PM EST - 8 months ago

Liquidia Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 8:15 PM EST - 8 months ago

Liquidia Slides: 44th Annual J.P. Morgan Healthcare Conference

Nov 18, 2025, 8:00 AM EST - 10 months ago

Liquidia Transcript: Jefferies London Healthcare Conference 2025

Nov 10, 2025, 4:15 PM EST - 10 months ago

Liquidia Transcript: UBS Global Healthcare Conference 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

Liquidia Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

Liquidia Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

Liquidia Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

Liquidia Slides: Q3 2025

Nov 3, 2025, 8:00 AM EST - 10 months ago

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

Oct 28, 2025, 3:00 PM EDT - 10 months ago

Liquidia Transcript: R&D Day 2025

Oct 28, 2025, 3:00 PM EDT - 10 months ago

Liquidia Slides: FY 2025

Oct 27, 2025, 8:30 AM EDT - 10 months ago

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

Oct 7, 2025, 6:30 AM EDT - 11 months ago

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

Sep 3, 2025, 3:45 PM EDT - 1 year ago

Liquidia Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Quarterly report: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Slides: Q2 2025

Aug 12, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jun 23, 2025, 4:34 PM EDT - 1 year ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Jun 4, 2025, 11:05 AM EDT - 1 year ago

Liquidia Transcript: Jefferies Global Healthcare Conference 2025

Jun 2, 2025, 6:30 AM EDT - 1 year ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

May 28, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Transcript: Status Update

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Slides: Status Update

May 23, 2025, 2:28 PM EDT - 1 year ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 13, 2025, 4:40 PM EDT - 1 year ago

Liquidia Transcript: BofA Securities 2025 Healthcare Conference

May 12, 2025, 6:00 AM EDT - 1 year ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q1 2025

May 8, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 2, 2025, 5:28 PM EDT - 1 year ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 1, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing

Apr 9, 2025, 8:45 AM EDT - 1 year ago

Liquidia Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 10:33 AM EDT - 1 year ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 9:30 AM EDT - 1 year ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Annual report: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q4 2024

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Liquidia Registration statement: Registration Filing

Mar 19, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Jan 15, 2025, 12:45 PM EST - 1 year ago

Liquidia Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 12:45 PM EST - 1 year ago

Liquidia Slides: FY 2025

Nov 19, 2024, 3:00 PM EST - 1 year ago

Liquidia Transcript: Stifel 2024 Healthcare Conference

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings Call Transcript: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Quarterly report: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings release: Q3 2024

Nov 13, 2024, 6:30 AM EST - 1 year ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 7, 2024, 10:00 AM EDT - 1 year ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 2, 2024, 6:00 AM EDT - 1 year ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Sep 30, 2024, 8:00 AM EDT - 1 year ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

kcphaeton Sep. 18 at 8:19 PM

0 · Reply

Georgeson Sep. 18 at 7:32 PM

2 · Reply

Hamboning2026 Sep. 18 at 5:48 PM

$LQDA This stock does not hold its gains. Not sure how much more that needs to be said. Again, puts are free money here.

0 · Reply

KeelinTime Sep. 18 at 10:10 AM

$LQDA

0 · Reply

Zoeyface Sep. 18 at 9:48 AM

$LQDA The dip that keeps dipping.

0 · Reply

SteelerJon Sep. 17 at 9:28 PM

$LQDA 😎🏦🏦 https://www.defenseworld.net/2026/09/15/california-state-teachers-retirement-system-acquires-5835156-shares-of-liquidia-corporation-lqda.html

0 · Reply

BDE_Worldwide Sep. 17 at 8:24 PM

$LQDA weird day… 🤔

0 · Reply

KeelinTime Sep. 17 at 7:19 PM

$LQDA

0 · Reply

MrMulally Sep. 17 at 2:27 PM

$LQDA $70 again!!! 👏👏

0 · Reply

MarketPro Sep. 17 at 12:49 PM

$LQDA Chart Update:

0 · Reply

Equibles Sep. 17 at 12:13 PM

$LQDA This one turned up on Equibles. Liquidia Corp director SINGH RAMAN reported selling 8,468 LQDA shares on September 14, 2026, worth about $560.2 thousand, in a non-derivative Form 4.

0 · Reply

judgeyoung2 Sep. 17 at 10:13 AM

$LQDA this Judge Andrews needs to resign in shame and hand the trial over to me. I will have a decision in 2 minutes.

0 · Reply

BullRun4 Sep. 16 at 9:10 PM

$LQDA The judge still not back from summer vacation?

1 · Reply

KeelinTime Sep. 16 at 8:04 PM

$LQDA

0 · Reply

judgeyoung2 Sep. 16 at 7:37 PM

$LQDA holding strong. Could be rounding out to push back to $90.

0 · Reply

MrMulally Sep. 16 at 3:46 PM

$LQDA very nice!!!

0 · Reply

BDE_Worldwide Sep. 16 at 2:35 PM

$LQDA adding on this dip.. know what you own.. 😉

0 · Reply

SteelerJon Sep. 16 at 1:16 AM

$LQDA 😎🏦🏦

0 · Reply

KeelinTime Sep. 15 at 5:55 PM

$LQDA

0 · Reply

Georgeson Sep. 15 at 5:28 PM

$MNKD To equate $LQDA market cap rise (which led to incredible share price rise) to MNKD market cap rise (which led to essentially flat share price over the last 10 years or just about any period of time) is so stupid that only @NatesNotes can be that stupid to convince suckers to subscribe to his newsletter. Thank you for your attention to this matter. #nateisanidiot #factsmatter #numbersdon'tLie I attack Nate because he is a freaking moron for various reasons. One of which is how he brags how smart he is and how dumb others are. My god, a normal person who is not pumping his newsletter would shut up, after saying super buy under $5 and buy under $10 for so many years.

0 · Reply

MrMulally Sep. 15 at 4:18 PM

$LQDA what a fight!!! 💪

0 · Reply

Hamboning2026 Sep. 15 at 2:01 PM

$LQDA And just like that.. Another 2% shaved off the share price.. Anyone with hopes and dreams that this stock will trade anywhere near $90 again is just delusional unfortunately.. Just buy puts and recuperate your missed gains on the inevitable drop under $50 soon.

0 · Reply

Market Cap	6.13B
Revenue (ttm)	158.32M
Net Income (ttm)	-68.92M
EPS (ttm)	N/A
PE Ratio	47.97
Forward PE	25.60
Profit Margin	-43.53%
Debt to Equity Ratio	0.90

Volume	3,895,703
Avg Vol	1,378,684
Day's Range	N/A - N/A
Shares Out	89.51M
Stochastic %K	70%
Beta	0.53
Analysts	Strong Sell
Price Target	$106.71